BX Stock Analysis: Blackstone | NYSE
Asset Management | NYSE, USA | Market Cap: 144.014m USD | 12M Return: -16.7% | US09260D1072 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 564M
EPS Trend: 97.6%
Qual. Beats: 0
Rev. Trend: 98.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Blackstone Inc. is a global alternative asset management firm that invests across multiple strategies, including private equity, venture capital, real estate, hedge fund solutions, credit, secondary fund of funds, and public debt and equity. The firm deploys capital across all stages of a companys lifecycle-from seed and early-stage ventures to mature buyouts and turnarounds-and pursues a wide range of transaction types such as large buyouts, recapitalizations, special situations, and growth equity investments.
Its real estate segment focuses on opportunistic and core+ investments as well as commercial real estate debt, with operations spanning North America, Europe, and Asia. Blackstone also operates fund-of-fund vehicles that allocate to private equity, venture capital, mezzanine, distressed, and real estate funds, and supports portfolio companies with in-house capital markets services.
As an alternative asset manager, Blackstones business model is built on raising capital from institutional and high-net-worth investors, then earning revenue through management fees on assets under management (AUM) and performance-based incentive fees (commonly known as carried interest) on investment gains. The firm invests across a broad set of industries including energy, financial services, consumer products, real estate, shipping, and infrastructure-related assets.
- Private credit and insurance AUM accelerate fee-related earnings growth
- BREIT redemption gates and real estate marks pressure distributable earnings
- IPO and exit market recovery boosts performance fee realizations
| Net Income: 3.56b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 3.90 > 1.0 |
| NWC/Revenue: 11.72% < 20% (prev -3.07%; Δ 14.79% < -1%) |
| CFO/TA 0.12 > 3% & CFO 5.96b > Net Income 3.56b |
| Net Debt (11.0b) to EBITDA (8.63b): 1.27 < 3 |
| Current Ratio: 1.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (800.0m) vs 12m ago 2.25% < -2% |
| Gross Margin: 89.70% > 18% (prev 95.97%; Δ -6.26% > 0.5%) |
| Asset Turnover: 33.88% > 50% (prev 26.39%; Δ 7.49% > 0%) |
| Interest Coverage Ratio: 15.79 > 6 (EBIT TTM 8.57b / Interest Expense TTM 543.1m) |
| A: 0.04 (Total Current Assets 10.4b - Total Current Liabilities 8.48b) / Total Assets 49.6b |
| B: -0.01 (Retained Earnings -383.2m / Total Assets 49.6b) |
| C: 0.18 (EBIT TTM 8.57b / Avg Total Assets 48.1b) |
| D: 0.31 (Book Value of Equity 8.84b / Total Liabilities 28.6b) |
| Altman-Z'' = 1.75 = BBB |
| DSRI: 0.97 (Receivables 6.96b/5.43b, Revenue 16.3b/12.3b) |
| GMI: 1.07 (GM 95.97% / 89.70%) |
| AQI: 0.83 (AQ_t 0.76 / AQ_t-1 0.92) |
| SGI: 1.33 (Revenue 16.3b / 12.3b) |
| TATA: -0.05 (NI 3.56b - CFO 5.96b) / TA 49.6b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of November 22, 2026, the stock is trading at USD 110.80 with a total of 6,712,698 shares traded. Over the past week, the price has changed by -7.81%, over one month by +1.37%, over three months by -20.87% and over the past year by -16.65%.
Current recommended Stop Loss: 104.50 (which is 5.7% or 1.6 ATR below the current price).
Blackstone has received a consensus analysts rating of 3.92. Therefore, it is recommended to buy BX.
- StrongBuy: 9
- Buy: 4
- Hold: 11
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 139.1 | 25.5% |
P/E Trailing = 25.9844
P/E Forward = 16.2602
P/S = 9.3105
P/B = 10.7526
P/EG = 1.1863
Revenue TTM = 16.3b USD
EBIT TTM = 8.57b USD
EBITDA TTM = 8.63b USD
Long Term Debt = 12.4b USD (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 14.2b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.0b USD (calculated: Debt 14.2b - CCE 3.21b)
Enterprise Value = 155b USD (144b + Debt 14.2b - CCE 3.21b)
Interest Coverage Ratio = 15.79 (Ebit TTM 8.57b / Interest Expense TTM 543.1m)
EV/FCF = 26.59x (Enterprise Value 155b / FCF TTM 5.83b)
FCF Yield = 3.76% (FCF TTM 5.83b / Enterprise Value 155b)
FCF Margin = 35.78% (FCF TTM 5.83b / Revenue TTM 16.3b)
Net Margin = 21.83% (Net Income TTM 3.56b / Revenue TTM 16.3b)
Gross Margin = 89.70% ((Revenue TTM 16.3b - Cost of Revenue TTM 1.68b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 3.12 (Enterprise Value 155b / Total Assets 49.6b)
Interest Expense / Debt = 3.83% (Interest Expense 543.1m / Debt 14.2b)
Taxrate = 15.83% (1.29b / 8.15b)
NOPAT = 7.22b (EBIT 8.57b * (1 - 15.83%))
Current Ratio = 1.23 (Total Current Assets 10.4b / Total Current Liabilities 8.48b)
Debt / Equity = 1.61 (Debt 14.2b / totalStockholderEquity, last quarter 8.84b)
Debt / EBITDA = 1.27 (Net Debt 11.0b / EBITDA 8.63b)
Debt / FCF = 1.88 (Net Debt 11.0b / FCF TTM 5.83b)
Total Stockholder Equity = 8.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.39% (Net Income 3.56b / Total Assets 49.6b)
RoE = 40.77% (Net Income TTM 3.56b / Total Stockholder Equity 8.72b)
RoCE = 40.50% (EBIT 8.57b / Capital Employed (Equity 8.72b + L.T.Debt 12.4b))
RoIC = 17.89% (NOPAT 7.22b / Invested Capital 40.3b)
WACC = 9.04% (E(144b)/V(158b) * Re(9.61%) + D(14.2b)/V(158b) * Rd(3.83%) * (1-Tc(0.16)))
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 90.45 | Cagr: 1.76%
[DCF] Terminal Value 75.78% ; FCFF base≈4.96b ; Y1≈5.68b ; Y5≈8.37b
[DCF] Fair Price = 134.9 (EV 112b - Net Debt 11.0b = Equity 101b / Shares 751.1m; r=9.04% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 97.59 | EPS CAGR: 20.41% | SUE: 0.62 | # QB: 0
Revenue Correlation: 98.34 | Revenue CAGR: 30.94% | SUE: -0.25 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.54 | Chg30d=-3.02% | Revisions=-67% | Analysts=14
EPS current Year (2026-12-31): EPS=5.92 | Chg30d=-0.45% | Revisions=-76% | GrowthEPS=+6.2% | GrowthRev=+13.1%
EPS next Year (2027-12-31): EPS=7.36 | Chg30d=-0.68% | Revisions=-23% | GrowthEPS=+24.4% | GrowthRev=+24.4%
[Analyst] Revisions Ratio: -60% (up=9, down=40)